instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'GANCICLOVIR SODIUM'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34362398 | 19,721,140 | 2021-08-06 |
What was the outcome of reaction 'Cerebral infarction'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Fatal | ReactionOutcome | CC BY | 34362398 | 20,481,367 | 2021-08-06 |
What was the outcome of reaction 'Disease progression'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Fatal | ReactionOutcome | CC BY | 34362398 | 20,499,227 | 2021-08-06 |
What was the outcome of reaction 'IIIrd nerve paralysis'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Fatal | ReactionOutcome | CC BY | 34362398 | 20,481,367 | 2021-08-06 |
What was the outcome of reaction 'Leukopenia'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Recovering | ReactionOutcome | CC BY | 34362398 | 20,484,324 | 2021-08-06 |
What was the outcome of reaction 'Loss of proprioception'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Recovering | ReactionOutcome | CC BY | 34362398 | 20,493,028 | 2021-08-06 |
What was the outcome of reaction 'Neutropenia'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Recovering | ReactionOutcome | CC BY | 34362398 | 20,484,324 | 2021-08-06 |
What was the outcome of reaction 'Post transplant lymphoproliferative disorder'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Recovering | ReactionOutcome | CC BY | 34362398 | 20,484,324 | 2021-08-06 |
What was the outcome of reaction 'Sensory loss'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Recovering | ReactionOutcome | CC BY | 34362398 | 20,484,324 | 2021-08-06 |
What was the outcome of reaction 'Viral myelitis'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Recovering | ReactionOutcome | CC BY | 34362398 | 20,493,028 | 2021-08-06 |
What was the dosage of drug 'CLONAZEPAM'? | Arterial spin labeling for presurgical localization of refractory frontal lobe epilepsy in children.
BACKGROUND
Epilepsy is one of the most common chronic neurological diseases. Despite the great variety and prevalence of antiepileptic drug treatments, one-third of epilepsies remain drug resistant. The frontal lobe is ... | 0.1 MILLIGRAM/KILOGRAM, DAILY | DrugDosageText | CC BY | 34362444 | 21,025,143 | 2021-08-06 |
What was the dosage of drug 'LACOSAMIDE'? | Arterial spin labeling for presurgical localization of refractory frontal lobe epilepsy in children.
BACKGROUND
Epilepsy is one of the most common chronic neurological diseases. Despite the great variety and prevalence of antiepileptic drug treatments, one-third of epilepsies remain drug resistant. The frontal lobe is ... | 6 MILLIGRAM/KILOGRAM, DAILY | DrugDosageText | CC BY | 34362444 | 21,025,150 | 2021-08-06 |
What was the dosage of drug 'VALPROATE SODIUM'? | Arterial spin labeling for presurgical localization of refractory frontal lobe epilepsy in children.
BACKGROUND
Epilepsy is one of the most common chronic neurological diseases. Despite the great variety and prevalence of antiepileptic drug treatments, one-third of epilepsies remain drug resistant. The frontal lobe is ... | 30 MILLIGRAM/KILOGRAM, DAILY | DrugDosageText | CC BY | 34362444 | 21,025,150 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated myocarditis'. | Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.
BACKGROUND
Immune checkpoint inhibitor (ICI) induced myocarditis is a rare, severe, and often fatal adverse event. Evidence to guide appropriate immunosuppressive therapy is scarce. We present a case of ICI-i... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 34365980 | 19,742,405 | 2021-08-09 |
What was the administration route of drug 'IPILIMUMAB'? | Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.
BACKGROUND
Immune checkpoint inhibitor (ICI) induced myocarditis is a rare, severe, and often fatal adverse event. Evidence to guide appropriate immunosuppressive therapy is scarce. We present a case of ICI-i... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34365980 | 19,742,405 | 2021-08-09 |
What was the administration route of drug 'NIVOLUMAB'? | Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.
BACKGROUND
Immune checkpoint inhibitor (ICI) induced myocarditis is a rare, severe, and often fatal adverse event. Evidence to guide appropriate immunosuppressive therapy is scarce. We present a case of ICI-i... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34365980 | 19,742,405 | 2021-08-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cystitis'. | Immunotherapy-Related Cystitis: Case Report and Review of the Literature.
Immune checkpoint inhibitors (ICIs) including anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA4) and anti-programmed death cell protein 1 (anti-PD1) have extended patient survival benefit and revolutionized cancer treatment. As ICIs re... | NIVOLUMAB, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 34366676 | 19,762,490 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Immunotherapy-Related Cystitis: Case Report and Review of the Literature.
Immune checkpoint inhibitors (ICIs) including anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA4) and anti-programmed death cell protein 1 (anti-PD1) have extended patient survival benefit and revolutionized cancer treatment. As ICIs re... | NIVOLUMAB, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 34366676 | 19,762,490 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Immunotherapy-Related Cystitis: Case Report and Review of the Literature.
Immune checkpoint inhibitors (ICIs) including anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA4) and anti-programmed death cell protein 1 (anti-PD1) have extended patient survival benefit and revolutionized cancer treatment. As ICIs re... | NIVOLUMAB, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 34366676 | 19,762,490 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With 177Lu-DOTATATE: A Case Report.
Primary cardiac paragangliomas are rare tumors. Metastatic disease is even rarer. Surgical management is technically challenging, and sometimes even impossible. Available therapeutic modalities f... | TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 34367072 | 19,967,041 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With 177Lu-DOTATATE: A Case Report.
Primary cardiac paragangliomas are rare tumors. Metastatic disease is even rarer. Surgical management is technically challenging, and sometimes even impossible. Available therapeutic modalities f... | DEXAMETHASONE, LUTETIUM OXODOTREOTIDE LU-177, METOPROLOL, ONDANSETRON, PRAZOSIN | DrugsGivenReaction | CC BY | 34367072 | 19,928,081 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With 177Lu-DOTATATE: A Case Report.
Primary cardiac paragangliomas are rare tumors. Metastatic disease is even rarer. Surgical management is technically challenging, and sometimes even impossible. Available therapeutic modalities f... | DEXAMETHASONE, LUTETIUM OXODOTREOTIDE LU-177, METOPROLOL, ONDANSETRON, PRAZOSIN | DrugsGivenReaction | CC BY | 34367072 | 19,928,081 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With 177Lu-DOTATATE: A Case Report.
Primary cardiac paragangliomas are rare tumors. Metastatic disease is even rarer. Surgical management is technically challenging, and sometimes even impossible. Available therapeutic modalities f... | DEXAMETHASONE, LUTETIUM OXODOTREOTIDE LU-177, METOPROLOL, ONDANSETRON, PRAZOSIN | DrugsGivenReaction | CC BY | 34367072 | 19,928,081 | 2021 |
What was the dosage of drug 'LUTETIUM OXODOTREOTIDE LU-177'? | Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With 177Lu-DOTATATE: A Case Report.
Primary cardiac paragangliomas are rare tumors. Metastatic disease is even rarer. Surgical management is technically challenging, and sometimes even impossible. Available therapeutic modalities f... | 40.7 GBQ, DISTRIBUTED OVER 4 INDUCTION CYCLES EVERY 8-10 WEEKS ADMINISTERED OVER 25 MINUTES) | DrugDosageText | CC BY | 34367072 | 19,928,081 | 2021 |
What was the outcome of reaction 'Neutropenia'? | Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With 177Lu-DOTATATE: A Case Report.
Primary cardiac paragangliomas are rare tumors. Metastatic disease is even rarer. Surgical management is technically challenging, and sometimes even impossible. Available therapeutic modalities f... | Recovered | ReactionOutcome | CC BY | 34367072 | 19,928,081 | 2021 |
What was the outcome of reaction 'Thrombocytopenia'? | Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With 177Lu-DOTATATE: A Case Report.
Primary cardiac paragangliomas are rare tumors. Metastatic disease is even rarer. Surgical management is technically challenging, and sometimes even impossible. Available therapeutic modalities f... | Recovered | ReactionOutcome | CC BY | 34367072 | 19,928,081 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acquired gene mutation'. | Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report.
Vaginal adenocarcinomas (VAC) are most often reported after intrauterine exposition to diethylstilbestrol (DES). Rarely, VACs are reported as a malignant transformation of vaginal adenosis or endometriosis, in the context of chro... | BEVACIZUMAB, CARBOPLATIN, CISPLATIN, DENOSUMAB, PACLITAXEL, PEMBROLIZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34367146 | 19,938,666 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report.
Vaginal adenocarcinomas (VAC) are most often reported after intrauterine exposition to diethylstilbestrol (DES). Rarely, VACs are reported as a malignant transformation of vaginal adenosis or endometriosis, in the context of chro... | BEVACIZUMAB, CARBOPLATIN, CISPLATIN, DENOSUMAB, PACLITAXEL, PEMBROLIZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34367146 | 19,938,666 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report.
Vaginal adenocarcinomas (VAC) are most often reported after intrauterine exposition to diethylstilbestrol (DES). Rarely, VACs are reported as a malignant transformation of vaginal adenosis or endometriosis, in the context of chro... | BEVACIZUMAB, CARBOPLATIN, CISPLATIN, DENOSUMAB, PACLITAXEL, PEMBROLIZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34367146 | 19,938,666 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vaginal adenocarcinoma'. | Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report.
Vaginal adenocarcinomas (VAC) are most often reported after intrauterine exposition to diethylstilbestrol (DES). Rarely, VACs are reported as a malignant transformation of vaginal adenosis or endometriosis, in the context of chro... | BEVACIZUMAB, CARBOPLATIN, CISPLATIN, DENOSUMAB, PACLITAXEL, PEMBROLIZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34367146 | 19,938,666 | 2021 |
What was the administration route of drug 'DENOSUMAB'? | Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report.
Vaginal adenocarcinomas (VAC) are most often reported after intrauterine exposition to diethylstilbestrol (DES). Rarely, VACs are reported as a malignant transformation of vaginal adenosis or endometriosis, in the context of chro... | Subcutaneous | DrugAdministrationRoute | CC BY | 34367146 | 19,938,666 | 2021 |
What was the outcome of reaction 'Neoplasm progression'? | Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report.
Vaginal adenocarcinomas (VAC) are most often reported after intrauterine exposition to diethylstilbestrol (DES). Rarely, VACs are reported as a malignant transformation of vaginal adenosis or endometriosis, in the context of chro... | Recovering | ReactionOutcome | CC BY | 34367146 | 19,938,666 | 2021 |
What was the outcome of reaction 'Vaginal adenocarcinoma'? | Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report.
Vaginal adenocarcinomas (VAC) are most often reported after intrauterine exposition to diethylstilbestrol (DES). Rarely, VACs are reported as a malignant transformation of vaginal adenosis or endometriosis, in the context of chro... | Recovering | ReactionOutcome | CC BY | 34367146 | 19,938,666 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Colon carcinoma presenting as ovarian metastasis.
An adnexal mass is a common gynecological finding. Most adnexal masses are benign neoplasms, especially in premenopausal women. Yet, here we report a premenopausal woman with an adnexal mass that turned out to be an ovarian metastasis from colon cancer. This case emphas... | BEVACIZUMAB, CAPECITABINE, FLUOROURACIL, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 34367398 | 19,952,903 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Colon carcinoma presenting as ovarian metastasis.
An adnexal mass is a common gynecological finding. Most adnexal masses are benign neoplasms, especially in premenopausal women. Yet, here we report a premenopausal woman with an adnexal mass that turned out to be an ovarian metastasis from colon cancer. This case emphas... | BEVACIZUMAB, CAPECITABINE, FLUOROURACIL, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY | 34367398 | 19,952,903 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug reaction with eosinophilia and systemic symptoms'. | Cerebral nocardiosis with osteomyelitis of skull vault complicating a primary neck lesion in an immunocompetent patient: a case report.
Nocardia infection is an uncommon and rare condition in immunocompetent patient. A case of cutaneous nocardiosis complicated with osteomyelitis of the vault scalp in a 64-year-old man,... | CEFAZOLIN, GENTAMICIN, PHYTONADIONE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34367428 | 19,721,300 | 2021 |
What was the administration route of drug 'PHYTONADIONE'? | Cerebral nocardiosis with osteomyelitis of skull vault complicating a primary neck lesion in an immunocompetent patient: a case report.
Nocardia infection is an uncommon and rare condition in immunocompetent patient. A case of cutaneous nocardiosis complicated with osteomyelitis of the vault scalp in a 64-year-old man,... | Oral | DrugAdministrationRoute | CC BY | 34367428 | 19,721,300 | 2021 |
What was the outcome of reaction 'Drug reaction with eosinophilia and systemic symptoms'? | Cerebral nocardiosis with osteomyelitis of skull vault complicating a primary neck lesion in an immunocompetent patient: a case report.
Nocardia infection is an uncommon and rare condition in immunocompetent patient. A case of cutaneous nocardiosis complicated with osteomyelitis of the vault scalp in a 64-year-old man,... | Recovering | ReactionOutcome | CC BY | 34367428 | 19,721,300 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic myeloid leukaemia'. | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | BLEOMYCIN SULFATE, CYCLOPHOSPHAMIDE, DACARBAZINE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINBLASTINE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY | 34367701 | 21,017,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myeloid leukaemia'. | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | BLEOMYCIN SULFATE, CYCLOPHOSPHAMIDE, DACARBAZINE, DOXORUBICIN, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINBLASTINE, VINCRISTINE | DrugsGivenReaction | CC BY | 34367701 | 20,991,318 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Second primary malignancy'. | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | BLEOMYCIN SULFATE, CYCLOPHOSPHAMIDE, DACARBAZINE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINBLASTINE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY | 34367701 | 21,017,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic response decreased'. | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | IMATINIB | DrugsGivenReaction | CC BY | 34367701 | 20,985,053 | 2021 |
What was the dosage of drug 'BLEOMYCIN SULFATE'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | UNK (2 CYCLES) | DrugDosageText | CC BY | 34367701 | 20,991,318 | 2021 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | UNK (3 CYCLES) | DrugDosageText | CC BY | 34367701 | 20,991,318 | 2021 |
What was the dosage of drug 'DACARBAZINE'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | UNK (2 CYCLES) | DrugDosageText | CC BY | 34367701 | 20,991,318 | 2021 |
What was the dosage of drug 'ETOPOSIDE'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | UNK (3 CYCLES) | DrugDosageText | CC BY | 34367701 | 20,991,318 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | UNK (3 CYCLES) | DrugDosageText | CC BY | 34367701 | 20,991,318 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | UNK (3 CYCLES) | DrugDosageText | CC BY | 34367701 | 20,991,318 | 2021 |
What was the dosage of drug 'VINBLASTINE'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | UNK (2 CYCLES) | DrugDosageText | CC BY | 34367701 | 20,991,318 | 2021 |
What was the dosage of drug 'VINCRISTINE'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | UNK (3 CYCLES) | DrugDosageText | CC BY | 34367701 | 20,991,318 | 2021 |
What was the outcome of reaction 'Chronic myeloid leukaemia'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | Fatal | ReactionOutcome | CC BY | 34367701 | 21,017,492 | 2021 |
What was the outcome of reaction 'Second primary malignancy'? | Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Hematological malignancies with a BCR-JAK2 rearrangement have been described only sporadically in the literature over the last three decades. Although most patients suffer from a chronic myeloid neoplasm with marked ... | Fatal | ReactionOutcome | CC BY | 34367701 | 21,017,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | COVID-19 and APOL-1 High-Risk Genotype-Associated Collapsing Glomerulonephritis.
Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the lungs and can lead to acute respiratory distress syndrome (ARDS). The ongoing global pandemic has created heal... | AMLODIPINE BESYLATE, ATORVASTATIN, FUROSEMIDE, HYDROXYCHLOROQUINE, METFORMIN HYDROCHLORIDE, REMDESIVIR | DrugsGivenReaction | CC BY | 34367703 | 19,908,526 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | AMLODIPINE BESYLATE, ASPIRIN, DEXAMETHASONE, HEPARIN SODIUM, HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE\LISINOPRIL, INSULIN GLARGINE, PIOGLITAZONE, SIMVASTATIN | DrugsGivenReaction | CC BY | 34367704 | 20,012,788 | 2021 |
What was the administration route of drug 'HEPARIN SODIUM'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | Other | DrugAdministrationRoute | CC BY | 34367704 | 20,059,490 | 2021 |
What was the administration route of drug 'OXYGEN'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | Nasal | DrugAdministrationRoute | CC BY | 34367704 | 20,061,390 | 2021 |
What was the dosage of drug 'CALCIUM CHLORIDE\POTASSIUM CHLORIDE\SODIUM CHLORIDE\SODIUM LACTATE'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | 200 MILLILITER, INTERVAL 1 HOUR | DrugDosageText | CC BY | 34367704 | 20,061,390 | 2021 |
What was the dosage of drug 'HEPARIN SODIUM'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | UNK;DRIP | DrugDosageText | CC BY | 34367704 | 20,012,788 | 2021 |
What was the dosage of drug 'INSULIN GLARGINE'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | 25 UNITS DAILY | DrugDosageText | CC BY | 34367704 | 20,012,788 | 2021 |
What was the dosage of drug 'OXYGEN'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | 2 LITER | DrugDosageText | CC BY | 34367704 | 20,061,390 | 2021 |
What was the dosage of drug 'SEVELAMER'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | 2400 MILLIGRAM, TID | DrugDosageText | CC BY | 34367704 | 20,061,390 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | Recovered | ReactionOutcome | CC BY | 34367704 | 20,012,788 | 2021 |
What was the outcome of reaction 'Acute respiratory failure'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | Recovered | ReactionOutcome | CC BY | 34367704 | 20,012,788 | 2021 |
What was the outcome of reaction 'Metabolic acidosis'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | Recovered | ReactionOutcome | CC BY | 34367704 | 20,012,788 | 2021 |
What was the outcome of reaction 'Rhabdomyolysis'? | Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review.
The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVI... | Recovered | ReactionOutcome | CC BY | 34367704 | 20,012,788 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bladder leukoplakia'. | Diffuse Leukoplakia of the Bladder Ostium-Sparing in Patient Treated with Leuprorelin for Breast Cancer.
A 55-year-old woman came to our attention in April 2020 referring haematuria, frequency and urgency. The patient referred previous treatment with leuprorelin 3.75 mg/2 ml for breast cancer three years ago. Urine cul... | LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY | 34367713 | 19,759,152 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute lymphocytic leukaemia recurrent'. | Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease?
The treatment of pediatric B-cell acute lymphoblastic leukemia (B-ALL) has undergone several recent advancements, leading to an increased amount of tre... | BLINATUMOMAB, BUSULFAN, FLUDARABINE PHOSPHATE, MELPHALAN | DrugsGivenReaction | CC BY-NC | 34367735 | 19,719,696 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease?
The treatment of pediatric B-cell acute lymphoblastic leukemia (B-ALL) has undergone several recent advancements, leading to an increased amount of tre... | BUSULFAN, FLUDARABINE PHOSPHATE, MELPHALAN | DrugsGivenReaction | CC BY-NC | 34367735 | 20,481,001 | 2021 |
What was the dosage of drug 'FLUDARABINE PHOSPHATE'? | Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease?
The treatment of pediatric B-cell acute lymphoblastic leukemia (B-ALL) has undergone several recent advancements, leading to an increased amount of tre... | 30 MG/M2 (FOR FOUR DOSES) | DrugDosageText | CC BY-NC | 34367735 | 20,481,003 | 2021 |
What was the outcome of reaction 'Acute lymphocytic leukaemia recurrent'? | Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease?
The treatment of pediatric B-cell acute lymphoblastic leukemia (B-ALL) has undergone several recent advancements, leading to an increased amount of tre... | Not recovered | ReactionOutcome | CC BY-NC | 34367735 | 19,719,696 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bipolar I disorder'. | Manic Episode Induced by Lamotrigine in Rapid Cycling Bipolar Disorder.
Bipolar disorder is characterized by persistent and/or recurrent mood changes between depressive and manic poles. Rapid cycling is a frequent, although underrecognized, condition in bipolar disorder, and it is known to worsen the prognosis of the d... | AMLODIPINE BESYLATE, ARIPIPRAZOLE, COCAINE, DIAZEPAM, FLURAZEPAM HYDROCHLORIDE, LAMOTRIGINE, LISINOPRIL, LITHIUM, LORAZEPAM, OLANZAPINE, VALPROATE SODIUM | DrugsGivenReaction | CC BY | 34367791 | 20,061,851 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Manic Episode Induced by Lamotrigine in Rapid Cycling Bipolar Disorder.
Bipolar disorder is characterized by persistent and/or recurrent mood changes between depressive and manic poles. Rapid cycling is a frequent, although underrecognized, condition in bipolar disorder, and it is known to worsen the prognosis of the d... | AMLODIPINE BESYLATE, ARIPIPRAZOLE, COCAINE, DIAZEPAM, FLURAZEPAM HYDROCHLORIDE, LAMOTRIGINE, LISINOPRIL, LITHIUM, LORAZEPAM, OLANZAPINE, VALPROATE SODIUM | DrugsGivenReaction | CC BY | 34367791 | 20,061,851 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle twitching'. | Manic Episode Induced by Lamotrigine in Rapid Cycling Bipolar Disorder.
Bipolar disorder is characterized by persistent and/or recurrent mood changes between depressive and manic poles. Rapid cycling is a frequent, although underrecognized, condition in bipolar disorder, and it is known to worsen the prognosis of the d... | AMLODIPINE BESYLATE, ARIPIPRAZOLE, COCAINE, DIAZEPAM, FLURAZEPAM HYDROCHLORIDE, LAMOTRIGINE, LISINOPRIL, LITHIUM, LORAZEPAM, OLANZAPINE, VALPROATE SODIUM | DrugsGivenReaction | CC BY | 34367791 | 20,061,851 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tremor'. | Manic Episode Induced by Lamotrigine in Rapid Cycling Bipolar Disorder.
Bipolar disorder is characterized by persistent and/or recurrent mood changes between depressive and manic poles. Rapid cycling is a frequent, although underrecognized, condition in bipolar disorder, and it is known to worsen the prognosis of the d... | AMLODIPINE BESYLATE, ARIPIPRAZOLE, COCAINE, DIAZEPAM, FLURAZEPAM HYDROCHLORIDE, LAMOTRIGINE, LISINOPRIL, LITHIUM, LORAZEPAM, OLANZAPINE, VALPROATE SODIUM | DrugsGivenReaction | CC BY | 34367791 | 20,061,851 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Coronavirus Disease 2019 (COVID-19)-Induced Takotsubo Cardiomyopathy Prognosis in Geriatric Setting.
An 86-year-old female with a past medical history of hypertension, vertebral fractures with chronic lumbar pain, hip fracture, osteoporosis, deafness, and microcytic anemia underwent hospital admission for emergency med... | ASPIRIN, ATORVASTATIN CALCIUM, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, CLOPIDOGREL BISULFATE, DEXAMETHASONE, HEPARIN SODIUM, HUMAN RED BLOOD CELL, OXYGEN, REMDESIVIR | DrugsGivenReaction | CC BY | 34367812 | 19,712,322 | 2021-07 |
What was the administration route of drug 'HEPARIN SODIUM'? | Coronavirus Disease 2019 (COVID-19)-Induced Takotsubo Cardiomyopathy Prognosis in Geriatric Setting.
An 86-year-old female with a past medical history of hypertension, vertebral fractures with chronic lumbar pain, hip fracture, osteoporosis, deafness, and microcytic anemia underwent hospital admission for emergency med... | Intravenous drip | DrugAdministrationRoute | CC BY | 34367812 | 19,712,322 | 2021-07 |
What was the dosage of drug 'OXYGEN'? | Coronavirus Disease 2019 (COVID-19)-Induced Takotsubo Cardiomyopathy Prognosis in Geriatric Setting.
An 86-year-old female with a past medical history of hypertension, vertebral fractures with chronic lumbar pain, hip fracture, osteoporosis, deafness, and microcytic anemia underwent hospital admission for emergency med... | 15 L/MIN | DrugDosageText | CC BY | 34367812 | 19,712,322 | 2021-07 |
What was the outcome of reaction 'Drug ineffective'? | Coronavirus Disease 2019 (COVID-19)-Induced Takotsubo Cardiomyopathy Prognosis in Geriatric Setting.
An 86-year-old female with a past medical history of hypertension, vertebral fractures with chronic lumbar pain, hip fracture, osteoporosis, deafness, and microcytic anemia underwent hospital admission for emergency med... | Fatal | ReactionOutcome | CC BY | 34367812 | 19,712,322 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Iatrogenic Iron Overload Causing Porphyria Cutanea Tarda in a Patient With a Rare Nonsense Heterozygous UROD Gene Mutation.
Porphyria cutanea tarda (PCT) is a rare dermatologic condition characterized by blistering of sun-exposed surfaces and elevated hepatic enzymes. It may infrequently occur as the primary presentati... | DIPHENHYDRAMINE, ERYTHROPOIETIN, IRON, PREDNISOLONE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 34367815 | 19,871,401 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Iatrogenic Iron Overload Causing Porphyria Cutanea Tarda in a Patient With a Rare Nonsense Heterozygous UROD Gene Mutation.
Porphyria cutanea tarda (PCT) is a rare dermatologic condition characterized by blistering of sun-exposed surfaces and elevated hepatic enzymes. It may infrequently occur as the primary presentati... | DIPHENHYDRAMINE, PREDNISONE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 34367815 | 19,835,619 | 2021-07 |
What was the administration route of drug 'TRIAMCINOLONE ACETONIDE'? | Iatrogenic Iron Overload Causing Porphyria Cutanea Tarda in a Patient With a Rare Nonsense Heterozygous UROD Gene Mutation.
Porphyria cutanea tarda (PCT) is a rare dermatologic condition characterized by blistering of sun-exposed surfaces and elevated hepatic enzymes. It may infrequently occur as the primary presentati... | Topical | DrugAdministrationRoute | CC BY | 34367815 | 19,835,619 | 2021-07 |
What was the dosage of drug 'IRON'? | Iatrogenic Iron Overload Causing Porphyria Cutanea Tarda in a Patient With a Rare Nonsense Heterozygous UROD Gene Mutation.
Porphyria cutanea tarda (PCT) is a rare dermatologic condition characterized by blistering of sun-exposed surfaces and elevated hepatic enzymes. It may infrequently occur as the primary presentati... | UNK, EVERY TWO WEEKS | DrugDosageText | CC BY | 34367815 | 19,871,401 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fungaemia'. | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature.
With the evolving COVID-19 pandemic, increasing concerns about invasive fungal infections have been reported particularly with the use of potent immunosuppressant medications to treat the immun... | FAVIPIRAVIR, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34367918 | 20,071,586 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Trichosporon infection'. | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature.
With the evolving COVID-19 pandemic, increasing concerns about invasive fungal infections have been reported particularly with the use of potent immunosuppressant medications to treat the immun... | FAVIPIRAVIR, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34367918 | 20,071,586 | 2021 |
What was the dosage of drug 'TOCILIZUMAB'? | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature.
With the evolving COVID-19 pandemic, increasing concerns about invasive fungal infections have been reported particularly with the use of potent immunosuppressant medications to treat the immun... | TOTAL DOSE OF 1200 MG, IN TWO SEPARATE DOSES | DrugDosageText | CC BY | 34367918 | 20,071,586 | 2021 |
What was the outcome of reaction 'Fungaemia'? | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature.
With the evolving COVID-19 pandemic, increasing concerns about invasive fungal infections have been reported particularly with the use of potent immunosuppressant medications to treat the immun... | Recovered | ReactionOutcome | CC BY | 34367918 | 20,071,586 | 2021 |
What was the outcome of reaction 'Trichosporon infection'? | Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature.
With the evolving COVID-19 pandemic, increasing concerns about invasive fungal infections have been reported particularly with the use of potent immunosuppressant medications to treat the immun... | Recovered | ReactionOutcome | CC BY | 34367918 | 20,071,586 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute lung injury'. | Case Report: A Squamous Cell Lung Carcinoma Patient Who Responded to Neoadjuvant Immunochemotherapy but Died From Anastomosis Leakage or/and irAEs: Immune Microenvironment and Genomic Features Changes.
Clinical trials indicated that PD-1/PD-L1 inhibitors significantly improve the survival rate of patients with advanced... | AMLODIPINE BESYLATE, CARBOPLATIN, NIVOLUMAB, PACLITAXEL | DrugsGivenReaction | CC BY | 34367960 | 20,046,536 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular graft complication'. | Case Report: A Squamous Cell Lung Carcinoma Patient Who Responded to Neoadjuvant Immunochemotherapy but Died From Anastomosis Leakage or/and irAEs: Immune Microenvironment and Genomic Features Changes.
Clinical trials indicated that PD-1/PD-L1 inhibitors significantly improve the survival rate of patients with advanced... | AMLODIPINE BESYLATE, CARBOPLATIN, NIVOLUMAB, PACLITAXEL | DrugsGivenReaction | CC BY | 34367960 | 20,046,536 | 2021 |
What was the administration route of drug 'AMLODIPINE BESYLATE'? | Case Report: A Squamous Cell Lung Carcinoma Patient Who Responded to Neoadjuvant Immunochemotherapy but Died From Anastomosis Leakage or/and irAEs: Immune Microenvironment and Genomic Features Changes.
Clinical trials indicated that PD-1/PD-L1 inhibitors significantly improve the survival rate of patients with advanced... | Oral | DrugAdministrationRoute | CC BY | 34367960 | 20,046,536 | 2021 |
What was the outcome of reaction 'Acute lung injury'? | Case Report: A Squamous Cell Lung Carcinoma Patient Who Responded to Neoadjuvant Immunochemotherapy but Died From Anastomosis Leakage or/and irAEs: Immune Microenvironment and Genomic Features Changes.
Clinical trials indicated that PD-1/PD-L1 inhibitors significantly improve the survival rate of patients with advanced... | Fatal | ReactionOutcome | CC BY | 34367960 | 20,046,536 | 2021 |
What was the outcome of reaction 'Vascular graft complication'? | Case Report: A Squamous Cell Lung Carcinoma Patient Who Responded to Neoadjuvant Immunochemotherapy but Died From Anastomosis Leakage or/and irAEs: Immune Microenvironment and Genomic Features Changes.
Clinical trials indicated that PD-1/PD-L1 inhibitors significantly improve the survival rate of patients with advanced... | Fatal | ReactionOutcome | CC BY | 34367960 | 20,046,536 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'SAPHO syndrome'. | Case Report: SAPHO Syndrome Mimicking Bone Metastases During Treatment With Pembrolizumab for Non-small Cell Lung Cancer.
A 69-year-old female with recurrent stage IV squamous cell lung carcinoma and metastatic abdominal lymph node but not bone metastases was being treated with pembrolizumab. Four months after starting... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34368186 | 19,728,645 | 2021 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Case Report: SAPHO Syndrome Mimicking Bone Metastases During Treatment With Pembrolizumab for Non-small Cell Lung Cancer.
A 69-year-old female with recurrent stage IV squamous cell lung carcinoma and metastatic abdominal lymph node but not bone metastases was being treated with pembrolizumab. Four months after starting... | UNK, 6 CYCLES | DrugDosageText | CC BY | 34368186 | 19,728,645 | 2021 |
What was the outcome of reaction 'SAPHO syndrome'? | Case Report: SAPHO Syndrome Mimicking Bone Metastases During Treatment With Pembrolizumab for Non-small Cell Lung Cancer.
A 69-year-old female with recurrent stage IV squamous cell lung carcinoma and metastatic abdominal lymph node but not bone metastases was being treated with pembrolizumab. Four months after starting... | Recovering | ReactionOutcome | CC BY | 34368186 | 19,728,645 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacterial infection'. | Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review.
BACKGROUND
The inflammatory myofibroblastic tumor (IMT) is a rare, idiopathic, usually benign, mass-forming disease with myofibroblastic proliferation and a varying amount of inflamm... | CELECOXIB, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34368338 | 19,741,687 | 2021-07-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholangitis'. | Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review.
BACKGROUND
The inflammatory myofibroblastic tumor (IMT) is a rare, idiopathic, usually benign, mass-forming disease with myofibroblastic proliferation and a varying amount of inflamm... | METHOTREXATE, VINBLASTINE, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY-NC | 34368338 | 19,749,838 | 2021-07-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review.
BACKGROUND
The inflammatory myofibroblastic tumor (IMT) is a rare, idiopathic, usually benign, mass-forming disease with myofibroblastic proliferation and a varying amount of inflamm... | METHOTREXATE, VINBLASTINE, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY-NC | 34368338 | 19,749,838 | 2021-07-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review.
BACKGROUND
The inflammatory myofibroblastic tumor (IMT) is a rare, idiopathic, usually benign, mass-forming disease with myofibroblastic proliferation and a varying amount of inflamm... | METHOTREXATE, VINBLASTINE, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY-NC | 34368338 | 19,749,838 | 2021-07-26 |
What was the outcome of reaction 'Bacterial infection'? | Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review.
BACKGROUND
The inflammatory myofibroblastic tumor (IMT) is a rare, idiopathic, usually benign, mass-forming disease with myofibroblastic proliferation and a varying amount of inflamm... | Not recovered | ReactionOutcome | CC BY-NC | 34368338 | 19,741,687 | 2021-07-26 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.